{reportSlug=global-recombinant-human-egf-market, reportId=124954, mktKeyword=Recombinant Human EGF, cagr=0.00, publishDate=Aug 2022, priceOption2=6800, reportTitle=Recombinant Human EGF Comprehensive Study by Application (Pharmaceuticals, Cosmetics, Others), Category (Heparin-binding EGF-like growth factor (HB-EGF), Amphiregulin (AR), Epiregulin (EPR), Transforming Growth Factor-α (TGF-α), Others), Indication (Wound Healing, Gastrointestinal Ulceration, Brain Tumor Therapy, Others), Form (Lyophilized Powder, Liquid, Others), Purity (98% SDS-PAGE, 95%-98% SDS-PAGE, <95% SDS-PAGE) Players and Region - Global Market Outlook to 2027, baseYr=2019, totalTableFig=212, priceOption1=3750, forecastYr=2027, noOfPages=199, reportKey=124469, breadcrum=Global Recombinant Human EGF}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Aug 2022 199 Pages 60 Tables Base Year: 2019 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner